國藥新藥治Delta病毒痊癒率100% 疫苗接種者血漿為原料
https://money.udn.com/money/story/5604/5726935?from=ednappsharing

國藥新藥治Delta病毒痊癒率100% 疫苗接種者血漿為原料 | 陸股透視 | 兩岸 | 經濟日報

大陸國藥集團中國生物研製的靜脈注射新冠病毒特效藥「人免疫球蛋白（pH4）」近日獲大陸國家藥品監督管理局批准開展臨床試驗。...

https://money.udn.com/money/story/5604/5726935?from=ednappsharing

No response has been written yet. It is recommended to maintain a healthy skepticism towards it.